Illustration showing myelin

What we're doing about progressive MS

More and more research into understanding and treating progressive MS is being done – and now there’s real momentum and hope of finding new treatments.

Progressive MS is our top research priority and that of the global research community. With new knowledge being gained, new projects funded and clinical trials underway, there’s hope on the horizon.

Find out more

Speak up for ocrelizumab for progressive MS

Ocrelizumab is the first licensed treatment for people with primary progressive MS. We're campaigning for it to be available to them on the NHS.

Tweet your MP to show up for ocrelizumab

Not on Twitter? Email your MP to show up for ocrelizumab